AL
Congress trade
Rep. Alan Lowenthal (D-CA) bought $1K-$15K of BioMarin Pharmaceutical Inc. (BMRN) stock
Alan Lowenthal, U.S. Representative (D-CA), disclosed a purchase of BioMarin Pharmaceutical Inc. (BMRN) stock worth $1K-$15K in a STOCK Act filing on Jan 21, 2018.
The trade happened on Jan 17, 2018, 4 days before it was made public.
BMRN has moved -34.8% since the trade date, from $89.64 to $58.44 (Oct 1, 2026 close).
- Traded
- Jan 17, 2018
- Disclosed
- Jan 21, 2018
- Filing delay
- 4 days
- Price since
- -34.8%
- Source
- STOCK Act disclosure
Other trades in this disclosure (2)
More BMRN insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.